bupropion has been researched along with Central Nervous System Disease in 2 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, FI | 1 |
| Blough, BE | 1 |
| Mascarella, SW | 1 |
| Navarro, HA | 1 |
| Lukas, RJ | 1 |
| Damaj, MI | 1 |
| Dewan, MJ | 1 |
| Anand, VS | 1 |
1 review available for bupropion and Central Nervous System Disease
| Article | Year |
|---|---|
Bupropion and bupropion analogs as treatments for CNS disorders.
Topics: Animals; Bupropion; Central Nervous System Diseases; Humans; Protein Binding; Treatment Outcome | 2014 |
1 other study available for bupropion and Central Nervous System Disease
| Article | Year |
|---|---|
Evaluating the tolerability of the newer antidepressants.
Topics: Antidepressive Agents; Bupropion; Central Nervous System Diseases; Citalopram; Cyclohexanols; Delaye | 1999 |